Description

Currently, there is significant controversy regarding management of thyroid nodules and thyroid cancer, which are both commonly encountered clinical problems in the Unites States. The purposes of this session are to 1) identify and discuss the epidemiology of thyroid nodules, risk factors for thyroid cancer, current approach to treatment, and outcomes; 2) explain how to focus the ultrasound exam and report to be of optimal help to the clinician; 3) discuss current controversies such as which sonographic features are suggestive of malignant versus benign pathology, which guidelines should be used to recommend FNA of thyroid nodules, the role of molecular markers in patient management; and 4) to differentiate between insufficient, indeterminate, and highly suspicious cytology classifications, and what each classification means to the surgeon and the need for repeat FNA. Such understanding is aimed at maximizing sensitivity for the accurate diagnosis of clinically significant thyroid cancer while minimizing unnecessary FNA and surgery. 

Subspecialties: HN, NIS, RE
Modalities: US

Speaker(s):

• Zubair Baloch, MD,PHD
• Edward Grant, MD, FACR
• Jill Langer, MD
• Susan Mandel, MD,MPH
• Carl Reading, MD, FACR
• Leslie Scoutt, MD, FACR
• Robert Udelsman, MBA,MD

Disclosures

• Leslie Scoutt, MD, FACR : Honoraria:  Phillips Healthcare; Research Grants: National Institute of Mental Health
• Jill Langer, MD : Consultant: BioClinica